A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients Presenting to the Emergency Department and to Evaluate Its Side Effect and Safety Profile When Used in This Clinical Situation.
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2015
At a glance
- Drugs Arformoterol (Primary) ; Levosalbutamol
- Indications Asthma; Bronchospasm
- Focus Therapeutic Use
- 28 Jun 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 14 Jan 2009 New trial record.